Rang	Name	Position
1	Mr. John J. Greisch M.B.A.	Executive Chairman of the Board
2	Mr. Alessandro Maselli	President, CEO & Director
3	Mr. Matti M. Masanovich	Senior VP & CFO
4	Ms. Lisa Evoli	Senior VP & Chief Human Resources Officer
5	Mr. Ricky Hopson	President, Division Head for BioProduct Delivery & Chief of Staff
6	Mr. David McErlane	Group President of Biologics Segment
7	Mr. Michael J. Hatzfeld Jr.	VP & Chief Accounting Officer
8	Mr. Charles Lickfold	Senior VP & Chief Information Officer
9	Mr. Paul Surdez	Vice President of Investor Relations
10	Mr. Joseph A. Ferraro J.D.	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,76%	1,01 Mrd. USD
2	Farallon Capital Management, L.L.C.	4,62%	0,53 Mrd. USD
3	State Street Corp	4,11%	0,47 Mrd. USD
4	Millennium Management LLC	2,49%	0,29 Mrd. USD
5	Barclays PLC	2,36%	0,27 Mrd. USD
6	Geode Capital Management, LLC	2,35%	0,27 Mrd. USD
7	Elliott Investment Management LP	2,20%	0,25 Mrd. USD
8	Davidson Kempner Capital Management LP	2,15%	0,25 Mrd. USD
9	UBS O'Connor LLC	2,12%	0,25 Mrd. USD
10	Balyasny Asset Management LLC	2,00%	0,23 Mrd. USD
11	Fidelity International Ltd	1,97%	0,23 Mrd. USD
12	JPMorgan Chase & Co	1,68%	0,19 Mrd. USD
13	Amvescap Plc.	1,60%	0,18 Mrd. USD
14	Bank of America Corp	1,45%	0,17 Mrd. USD
15	Bank of Montreal	1,00%	0,12 Mrd. USD
16	BMO Capital Markets Corp.	1,00%	0,12 Mrd. USD
17	Northern Trust Corp	0,87%	0,10 Mrd. USD
18	Deutsche Bank AG	0,87%	0,10 Mrd. USD
19	Natixis SA	0,85%	0,10 Mrd. USD
20	Morgan Stanley - Brokerage Accounts	0,80%	0,09 Mrd. USD